Inquiry into price-fixing in pharmaceutical industry
News | 26 February 2013
The Commerce Commission says it is investigating allegations of price-fixing within the pharmaceutical industry. The allegations follow changes to the Community Pharmacy Services Agreement in July 2012 that prohibited pharmacies from discounting ...
Click on the link to read the full article at Radio New Zealand
(This link will open in a new window)
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
